Coronavirus
The US Has Approved Gilead’s Antiviral Drug Remdesivir To Treat Patients With COVID-19
(Reuters) – The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc (GILD.O) for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
During a meeting in the Oval Office with President Donald Trump, Gilead Chief Executive Daniel O’Day called the move an important first step and said the company was donating 1.5 million vials of the drug to help patients.
Gilead said on Wednesday the drug had helped improve outcomes for patients with COVID-19, the disease caused by the coronavirus, and provided data suggesting it worked better when given earlier in the course of infection.
The closely watched drug has moved financial markets in recent weeks, following the release of several studies that painted a mixed picture of its effectiveness.
Vice President Mike Pence said the 1.5 million vials would start being distributed to hospitals on Monday.
Kenya Insights allows guest blogging, if you want to be published on Kenya’s most authoritative and accurate blog, have an expose, news TIPS, story angles, human interest stories, drop us an email on [email protected] or via Telegram
Ukraine Expected To Give Up Land, Some Arms Under US Peace Plan, Sources Say
Watch Live: President Ruto State Of The Nation Address
What Really Happens to Your M-Pesa Balance When You Die
Linus Kaikai Among 920 New Kenyan Advocates Admitted To The Bar
KRA To Cut More From Kenya Meta Content Creators Payouts
Google Unveils Gemini 3, Its Most Advanced AI Yet, With Immediate Integration Into Search
Uchumi CEO Lawrence Ngao Charged with Stealing Sh135,000 Chimney Fan
Blow to Guyo as Court Stops Sh7.3bn Isiolo Budget Over Corruption Loopholes
I Had Warned Raila Of Possible Fallout In The Odinga Family After His Death, Oburu Says
Boda Boda Rider Slaughtered in South B Airbnb After iPhone 17 Delivery as Kisii Rider Is Tortured by Thugs He Tried to Expose
DEATH TRAPS IN THE SKY: Inside the Sordid World of West Rift Aviation’s Deadly Corruption Cartel
SAFARICOM’S M-SHWARI MELTDOWN: TERRIFIED KENYANS FLEE AS BILLIONS VANISH INTO DIGITAL BLACK HOLE
EX–YOUTH FUND BOSS GOR SEMELANG’O JAILED IN DUBAI OVER MONEY LAUNDERING LINKS
Equity Bank CEO James Mwangi Kicked Out of Sh1 Billion Muthaiga Mansion
Ruto’s Reshuffle Storm As Moi, Ida Odinga Tipped To Join His Cabinet
Whose Drugs? Kenya Navy Seizes Drug Ship In Mombasa Carrying Sh8.2 Billion Meth
BLOOD IN THE SKIES: Eleven Dead as West Rift Aviation’s Chickens Come Home to Roost in Kwale Horror Crash
Kakuzi Investors Face Massive Loss as Land Commission Drops Bombshell Order to Surrender Quarter of Productive Estate
EX-YOUTH FUND BOSS GOR SEMELANG’O JAILED IN DUBAI FOR DEFRAUDING BUSINESSWOMAN
EXPLOSIVE DOSSIER: THE SECRET FILE THAT COULD DESTROY CAREERS – INSIDE KERRA’S SHOCKING CERTIFICATE SCANDAL
-
Business2 days agoKakuzi Investors Face Massive Loss as Land Commission Drops Bombshell Order to Surrender Quarter of Productive Estate
-
Politics2 weeks agoODM Shuts Door on Gachagua Alliance, Signals Long-Term Deal with Ruto Ahead of 2027
-
Politics2 weeks agoUhuru Kenyatta Draws Battle Lines in Mt. Kenya Politics Defends Gachagua and Warns Jubilee Rebels to Toe the Line
-
News2 weeks agoBusinessman Adan Haji Isaack on Spot for Allegedly Harassing City Professor Over Disputed Land
-
Investigations2 weeks agoPeter Agoro Legal Battles Reveal How EACC Framed a Whistleblower to Protect Corrupt Elites
-
News2 weeks agoKenyan Activists Bob Njagi and Nicholas Oyoo Released After 38 Days in Ugandan Custody
-
Investigations2 weeks agoEXCLUSIVE: The $1.7 Billion Oil Heist That’s Starving South Sudan While Elites Feast on Blood Money
-
Politics1 week agoRuto Set to Dominate ODM@20 in Mombasa, Positioning Himself as Raila Odinga’s Political Heir Ahead of 2027